Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 208       

   Table of Contents      
ORIGINAL ARTICLE
Year : 2017  |  Volume : 145  |  Issue : 1  |  Page : 28-32

Coexistence of celiac disease & type 1 diabetes mellitus in children


Department of Pediatrics, Lady Hardinge Medical College, Kalawati Saran Children's Hospital, New Delhi, India

Date of Submission02-Mar-2015
Date of Web Publication30-May-2017

Correspondence Address:
Anju Seth
Department of Pediatrics, Lady Hardinge Medical College, Kalawati Saran Children's Hospital, New Delhi 110 001
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/ijmr.IJMR_199_15

Rights and Permissions
   Abstract 

Background & objectives: Type 1 diabetes mellitus (T1DM) and celiac disease (CD) tend to co-exist due to similar underlying genetic predisposition. Failure to recognize CD in patients with T1DM predisposes them to complications. The present study was aimed to assess children with T1DM for the presence of CD.
Methods: This was a retrospective analysis of the records of children with T1DM attending paediatric endocrinology clinic at a tertiary care hospital in north India from January 2006 to May 2014. All children were screened for CD at the time of diagnosis of T1DM using IgA anti-tissue transglutaminase (anti-tTG) levels in serum. Seropositive children were subjected to upper gastrointestinal endoscopy and duodenal biopsy for histopathological confirmation. The children also underwent thyroid function testing (TFT); those with deranged TFT were evaluated for thyroid-specific antibodies.
Results: Positive serology for CD was present in 43 of 126 children with T1DM whose records were reviewed [34.1%; 95% confidence interval (CI): 25.9-43.1]. Confirmed CD was diagnosed in 17 (13.5%; CI: 8.1-20.7) of the children screened and 17 of 40 (42.5%; CI: 27.1-59.1) seropositive participants. Four out of 17 children with coexisting CD and T1DM also had autoimmune thyroiditis with overt hypothyroidism. The children with confirmed CD were more likely to have short stature [odds ratios (OR)-3.16; 95% CI: 1.09-9.20, P<0.05] and hypothyroidism (OR-6.4; 95% CI: 1.52-26.90, P<0.05).
Interpretation & conclusions: Our study showed a higher proportion of CD in children with T1DM as compared to that reported in general population. Regular screening of children with T1DM for CD is needed to improve metabolic control and prevent long-term complications.

Keywords: Anti-tissue transglutaminase antibody - celiac disease - children - hypothyroidism - type 1 diabetes mellitus


How to cite this article:
Singh P, Seth A, Kumar P, Sajjan S. Coexistence of celiac disease & type 1 diabetes mellitus in children. Indian J Med Res 2017;145:28-32

How to cite this URL:
Singh P, Seth A, Kumar P, Sajjan S. Coexistence of celiac disease & type 1 diabetes mellitus in children. Indian J Med Res [serial online] 2017 [cited 2019 Jan 15];145:28-32. Available from: http://www.ijmr.org.in/text.asp?2017/145/1/28/207231

Celiac disease (CD) is an immune-mediated multisystem disorder seen in genetically susceptible individuals triggered by gluten and related prolamins in wheat, rye and barley. The coexistence of type 1 diabetes mellitus (T1DM) and CD is due to intricate interaction between the environmental factors and genetic susceptibility. There is evidence of common genetic basis for disease expression as both the diseases are associated with the major histocompatibility complex class II antigen DQ2 encoded by the alleles, DQA1*501 and DQB1*201 and seven shared non-human leucocyte antigen (HLA) loci [1]. Globally, the estimated prevalence of CD in the general population is around 1 per cent [2] which rises 5 to 7 folds in association with T1DM [3],[4],[5]. This variation in coexistence is determined by geographical/genetic predisposition and diabetes duration. In north India, the prevalence of CD in general population has been reported as 1.04 per cent [6], while in south India, the disease has been infrequent and its prevalence has not been established. The prevalence of CD in association with T1DM was reported as 11[7] and 17 per cent [8] from two studies from north India.

CD has protean manifestations, but majority of patients with coexisting T1DM do not have classical gastrointestinal symptoms of CD. They are either asymptomatic or manifest with atypical features such as short stature, refractory anaemia, delayed puberty, osteopenia and other autoimmune disorders such as thyroiditis and autoimmune hepatitis [3],[9]. Clinical clues suggestive of CD in T1DM include unpredictable blood glucose levels, recurrent episodes of hypoglycaemia and growth failure [10]. These symptoms are often attributed to poor glycaemic control per se. Failure to recognize co-existing CD may predispose the individuals to increased risk of growth failure, osteoporosis, infertility and gastrointestinal lymphoma [11]. It is also speculated that continuous exposure to gluten may facilitate development and progression of other autoimmune diseases apart from CD [12]. It therefore, becomes important to actively screen for CD in patients with T1DM at the time of diagnosis of T1DM and also during follow up later in life. This will help optimize insulin therapy, achieve good glycaemic control and avert the risk of complications both due to T1DM and CD [13]. The present study was conducted to assess the coexistence of CD in children with T1DM in a tertiary care hospital in north India.


   Material & Methods Top


This was a retrospective analysis of the records of children with T1DM attending the paediatric endocrinology clinic on a regular basis for atleast one year, at Lady Hardinge Medical College, a tertiary level teaching hospital in New Delhi, India, from January 2006 to May 2014. As per the clinic's protocol, all children diagnosed with T1DM were screened for CD at enrolment by IgA anti-tissue transglutaminase (anti-tTG) levels in the serum. The samples for IgA anti-tTG were analyzed using ELISA kits based on solid-phase enzyme immunoassays (Kit: tTG-A ELISA REF EIA - 31003, 31004; Euroimmune, Germany) with a sensitivity of 95 per cent and specificity of 96 per cent. Children meeting the reference cut-off level of anti-tTG IgA ≥15 U/ml were considered as seropositive. Among the seropositive group, those with anti-tTG levels ≥3 times the reference cut-off were advised endoscopic biopsy as per the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition criteria [14]. Serum IgA levels were measured in children with negative celiac serology to detect IgA deficiency. Seronegative children were considered for re-testing over subsequent visits in the presence of poor metabolic control and frequent hypoglycaemic episodes. Upper gastrointestinal (UGI) endoscopy and biopsy were performed after obtaining written informed consent. The severity of inflammatory process was graded on histopathology using modified Marsh classification [15]. A diagnosis of CD was established when the biopsy showed Marsh Grade 2 or 3 in the presence of seropositivity. The children were regularly followed up in the clinic as per protocol that included monitoring growth parameters, insulin compliance and blood glucose levels. Children with height for age below −2 standard deviation for age as well as gender-related norms were considered to have short stature. All children underwent thyroid function testing (TFT) while thyroid-specific antibodies were analyzed only in those with deranged thyroid function. Children with CD and hypothyroidism were managed as per the standard protocol. The study protocol was approved by the Institutional Ethics Committee.

Statistical analysis: The data were analyzed using SPSS software version 16.0 (SPSS Inc., Chicago, USA). Proportion of children with seropositivity and confirmed CD was calculated and 95 per cent confidence interval (CI) was determined by exact method [16]. Simple logistic regression [17] was applied to study the association of variables (like age, sex, height, BMI, HbA1c levels) in type 1 DM with celiac seropositivity and confirmed CD. The odds ratios (ORs) with 95 per cent CI were calculated for the same.


   Results Top


Records of 126 children and adolescents (62 boys and 64 girls) with T1DM were reviewed. The mean age at enrolment was 8.2±4 and 8.1±3.8 yr for boys and girls, respectively. Forty three children (34.1%; 95% CI: 25.9-43.1) were seropositive for CD with anti-tTG levels >3 times of the reference cut-off. None of the participants with negative serology were found to be IgA deficient. There was no significant difference among seropositive and seronegative individuals in age at presentation (OR-2.21; CI: 0.64-7.75, P=0.20), gender (OR-0.64; CI: 0.30-1.34, P=0.24), body mass index (BMI) (OR-2.18; CI: 0.91-5.20, P=0.08), baseline glycated haemoglobin (HbA1c) (OR-1.08; CI: 0.95-1.23, P=0.22) and prevalence of co-existing hypothyroidism (OR-2.60; CI: 0.66-10.23, P=0.17). However, the probability of finding short stature was more among seropositive as compared to seronegative children (OR-2.26; CI: 1.06-4.79, P<0.05).

Duodenal biopsy was performed in 40 seropositive children. The remaining three children did not give consent for UGI endoscopy as they were asymptomatic with a good metabolic control. Histopathologically confirmed CD was diagnosed in 17 of 126 children (13.5%, 95% CI: 8.1-20.7). Eight children had a normal biopsy, 12 showed non-specific duodenitis and the remaining three had Marsh Grade I. In two cases, CD was diagnosed before they developed features of T1DM. In the remaining cases, the diagnosis of CD was made either concurrent or within two years of the diagnosis of T1DM. None of the children with CD exhibited typical gastrointestinal symptoms. Concomitant autoimmune thyroiditis with hypothyroidism was diagnosed in nine (7.1%) children, while four (3.1%) had coexistence of CD, T1DM and autoimmune thyroiditis. There was no difference in age at presentation (OR-2.68; CI: 0.31-23.35, P=0.37), sex (OR-0.52; CI: 0.18-1.49, P=0.52) and BMI (OR-0.76; CI: 0.20-2.86, P=0.68) among patients with and without CD. However, concomitant short stature (OR-3.16; 95% CI: 1.09-9.20, P<0.05) and hypothyroidism (OR-6.4; 95% CI: 1.52-26.90, P<0.05) were associated with significantly higher odds of CD.

Fifteen children in whom CD was diagnosed on screening exhibited poor metabolic control in spite of good compliance with insulin and diet before institution of gluten-free diet (GFD). They experienced frequent postprandial and early morning hypoglycaemia on an average of 8-10 episodes/month over three months before the diagnosis of CD was established. Following the institution of GFD in this subgroup, there were no further hypoglycaemic episodes without significant change in insulin requirement and HbA1c levels.


   Discussion Top


The coexistence of CD and T1DM reported in our study was comparable to that reported in other studies from north India [7],[8]. The reported prevalence of CD in the general population in north India is 1.04 per cent [6]. The global prevalence of biopsy-proven CD in children with TIDM varies from 2.4 per cent in Finland to 16.4 per cent in Algeria [18]. The difference in the prevalence of CD across geographical locations was found to be due to difference in distribution of the HLA genotypes and its complex interaction with the environment and host immunological factors [19]. The association of T1DM and CD in north Indian population may be attributed to microsatellite polymorphism in major histocompatibility complex class I chain [20]. A multicentre study from Italy has demonstrated a positive association between young age at diabetes onset, female gender and the development of CD [21]. The global prevalence of IgA deficiency is variable, and a low prevalence reported in north Indian population [22] can possibly explain the absence of IgA deficiency in our study group.

The sequence of appearance of T1DM and CD cannot be predicted. A large proportion of CD cases are diagnosed within two years of T1DM and majority within 10 yr of screening in paediatric setting; however, the diagnosis can be made beyond this period [23]. The diagnosis of T1DM usually precedes CD [23],[24] though the order can also be reversed [25]. In a prospective study, 2.4 per cent children with T1DM had CD at the outset and another 2.8 per cent seroconverted over a median interval of 3.6 yr [26]. In our study only 13.5 per cent children were found with T1DM and biopsy-proven CD, with a large pool of potential celiac patients to monitor for the future development of disease. This mandates screening for CD in T1DM at presentation as most children are asymptomatic and continued regular monitoring after every 1-2 years [13].

The observation of short stature being significantly associated with coexisting T1DM and CD in the current study was in agreement with reports from Indian [7],[27] and other studies [28]. In addition, coexisting hypothyroidism increased the odds of CD in children with T1DM, and a similar association of autoimmune diseases with T1DM has been reported in literature [29],[30]. Hypoglycaemia has been anecdotally described as a warning sign of CD in diabetes due to erratic absorption of nutrients [10]. Even though we reported reduced hypoglycaemic events after institution of GFD in children with CD and T1DM, its effect on clinical/metabolic parameters has been variably reported [26],[31],[32]. The limitation of the present study was its retrospective design and variable duration of follow up.

In conclusion, our findings showed a high proportion of CD in children with T1DM, the odds of which increased in the presence of short stature and hypothyroidism. Cohort studies with a robust study design are warranted for drawing firm conclusions.

Conflicts of Interest: None.



 
   References Top

1.
Smyth DJ, Plagnol V, Walker NM, Cooper JD, Downes K, Yang JH, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008; 359 : 2767-77.  Back to cited text no. 1
    
2.
Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: A large multicenter study. Arch Intern Med 2003; 163 : 286-92.  Back to cited text no. 2
    
3.
Gillett PM, Gillett HR, Israel DM, Metzger DL, Stewart L, Chanoine JP, et al. High prevalence of celiac disease in patients with type 1 diabetes detected by antibodies to endomysium and tissue transglutaminase. Can J Gastroenterol 2001; 15 : 297-301.  Back to cited text no. 3
    
4.
Schuppan D, Hahn EG. Celiac disease and its link to type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2001; 14 (Suppl 1) : 597-605.  Back to cited text no. 4
    
5.
Mahmud FH, Murray JA, Kudva YC, Zinsmeister AR, Dierkhising RA, Lahr BD, et al. Celiac disease in type 1 diabetes mellitus in a North American community: Prevalence, serologic screening, and clinical features. Mayo Clin Proc 2005; 80 : 1429-34.  Back to cited text no. 5
    
6.
Makharia GK, Verma AK, Amarchand R, Bhatnagar S, Das P, Goswami A, et al. Prevalence of celiac disease in the northern part of India: A community based study. J Gastroenterol Hepatol 2011; 26 : 894-900.  Back to cited text no. 6
    
7.
Bhadada SK, Kochhar R, Bhansali A, Dutta U, Kumar PR, Poornachandra KS, et al. Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in North India. J Gastroenterol Hepatol 2011; 26 : 378-81.  Back to cited text no. 7
    
8.
Agrawal RP, Rathore A, Joshi A, Changal H, Kochar DK. Prevalence of celiac disease in type 1 diabetes mellitus in North West Rajasthan, India. Diabetes Res Clin Pract 2008; 79 : e15-6.  Back to cited text no. 8
    
9.
Rami B, Sumnik Z, Schober E, Waldhör T, Battelino T, Bratanic N, et al. Screening detected celiac disease in children with type 1 diabetes mellitus: Effect on the clinical course (a case control study). J Pediatr Gastroenterol Nutr 2005; 41 : 317-21.  Back to cited text no. 9
    
10.
Mohn A, Cerruto M, Iafusco D, Prisco F, Tumini S, Stoppoloni O, et al. Celiac disease in children and adolescents with type I diabetes: Importance of hypoglycemia. J Pediatr Gastroenterol Nutr 2001; 32 : 37-40.  Back to cited text no. 10
    
11.
Goddard CJR, Gillett HR. Complications of coeliac diseases: are all patients at risk? Postgrad Med J 2006; 82 : 705-12.  Back to cited text no. 11
    
12.
Toscano V, Conti FG, Anastasi E, Mariani P, Tiberti C, Poggi M, et al. Importance of gluten in the induction of endocrine autoantibodies and organ dysfunction in adolescent celiac patients. Am J Gastroenterol 2000; 95 : 1742-8.  Back to cited text no. 12
    
13.
Kordonouri O, Klingensmith G, Knip M, Holl RW, Aanstoot HJ, Menon PS, et al. ISPAD Clinical Practice Consensus Guidelines 2014. Other complications and diabetes-associated conditions in children and adolescents. Pediatr Diabetes 2014; 15 (Suppl 20) : 270-8.  Back to cited text no. 13
    
14.
Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R, et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54 : 136-60.  Back to cited text no. 14
    
15.
Dickson BC, Streutker CJ, Chetty R. Coeliac disease: an update for pathologists. J Clin Pathol 2006; 59 : 1008-16.  Back to cited text no. 15
    
16.
Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934; 26 : 404-13.  Back to cited text no. 16
    
17.
Hosmer DW, Lemeshow S. Applied logistic regression, 2nd ed. New York: John Wiley and Sons; 2000.  Back to cited text no. 17
    
18.
Sud S, Marcon M, Assor E, Palmert MR, Daneman D, Mahmud FH. Celiac disease and pediatric type 1 diabetes: Diagnostic and treatment dilemmas. Int J Pediatr Endocrinol 2010; 2010 : 161285.  Back to cited text no. 18
    
19.
Kang JY, Kang AH, Green A, Gwee KA, Ho KY. Systematic review: Worldwide variation in the frequency of coeliac disease and changes over time. Aliment Pharmacol Ther 2013; 38 : 226-45.  Back to cited text no. 19
    
20.
Kumar N, Sharma G, Kaur G, Tandon N, Bhatnagar S, Mehra N. Major histocompatibility complex class I chain related gene-A microsatellite polymorphism shows secondary association with type 1 diabetes and celiac disease in North Indians. Tissue Antigens 2012; 80 : 356-62.  Back to cited text no. 20
    
21.
Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C; Diabetes Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: An Italian multicenter study. Diabetes Care 2004; 27 : 1294-8.  Back to cited text no. 21
    
22.
Chandran S, Khetan D, Chaudhary R, Misra R, Aggarwal A. Low prevalence of IgA deficiency in north Indian population. Indian J Med Res 2006; 123 : 653-6.  Back to cited text no. 22
    
23.
Larsson K, Carlsson A, Cederwall E, Jönsson B, Neiderud J, Jonsson B, et al. Annual screening detects celiac disease in children with type 1 diabetes. Pediatr Diabetes 2008; 9 : 354-9.  Back to cited text no. 23
    
24.
Barera G, Bonfanti R, Viscardi M, Bazzigaluppi E, Calori G, Meschi F, et al. Occurrence of celiac disease after onset of type 1 diabetes: A 6-year prospective longitudinal study. Pediatrics 2002; 109 : 833-8.  Back to cited text no. 24
    
25.
Valerio G, Maiuri L, Troncone R, Buono P, Lombardi F, Palmieri R, et al. Severe clinical onset of diabetes and increased prevalence of other autoimmune diseases in children with coeliac disease diagnosed before diabetes mellitus. Diabetologia 2002; 45 : 1719-22.  Back to cited text no. 25
    
26.
Glastras SJ, Craig ME, Verge CF, Chan AK, Cusumano JM, Donaghue KC. The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and celiac disease and microvascular complications. Diabetes Care 2005; 28 : 2170-5.  Back to cited text no. 26
    
27.
Bhadada SK, Bhansali A, Ravikumar P, Kochhar R, Nain CK, Dutta P, et al. Changing scenario in aetiological profile of short stature in India-growing importance of celiac disease: A study from tertiary care centre. Indian J Pediatr 2011; 78 : 41-4.  Back to cited text no. 27
    
28.
Westman E, Ambler GR, Royle M, Peat J, Chan A. Children with coeliac disease and insulin dependent diabetes mellitus – Growth, diabetes control and dietary intake. J Pediatr Endocrinol Metab 1999; 12 : 433-42.  Back to cited text no. 28
    
29.
Kota SK, Meher LK, Jammula S, Kota SK, Modi KD. Clinical profile of coexisting conditions in type 1 diabetes mellitus patients. Diabetes Metab Syndr 2012; 6 : 70-6.  Back to cited text no. 29
    
30.
Ergür AT, Oçal G, Berberoglu M, Adiyaman P, Siklar Z, Aycan Z, et al. Celiac disease and autoimmune thyroid disease in children with type 1 diabetes mellitus: Clinical and HLA-genotyping results. J Clin Res Pediatr Endocrinol 2010; 2 : 151-4.  Back to cited text no. 30
    
31.
Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, Dunger DB. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 2002; 25 : 1117-22.  Back to cited text no. 31
    
32.
Fröhlich-Reiterer EE, Kaspers S, Hofer S, Schober E, Kordonouri O, Pozza SB, et al. Anthropometry, metabolic control, and follow-up in children and adolescents with type 1 diabetes mellitus and biopsy-proven celiac disease. J Pediatr 2011; 158 : 589-93.e2.  Back to cited text no. 32
    



This article has been cited by
1 Clinical guidelines on the diagnosis and treatment of celiac disease in Mexico
J.M. Remes-Troche,L.F. Uscanga-Domínguez,R.G. Aceves-Tavares,A.M. Calderón de la Barca,R.I. Carmona-Sánchez,E. Cerda-Contreras,E. Coss-Adame,M.E. Icaza-Chávez,A. Lopéz-Colombo,M.P. Milke-García,M. Morales-Arámbula,M. Peláez-Luna,P. Ramos Martínez,S. Sánchez-Sosa,M.C. Treviño-Mejía,R. Vázquez-Frías,L.B. Worona-Dibner,L.E. Zamora-Nava,A. Rubio-Tapia
Revista de Gastroenterología de México (English Edition). 2018;
[Pubmed] | [DOI]
2 Celiac antibodies in children with type 1 diabetes – A diagnostic validation study
Katarzyna Lewandowska,Olga Ciepiela,Agnieszka Szypowska,Jan Wyhowski,Eliza Glodkowska-Mrówka,Katarzyna Popko,Magdalena Ostafin,Beata Pyrzak,Urszula Demkow
Autoimmunity. 2018; : 1
[Pubmed] | [DOI]
3 Guía clínica para diagnóstico y tratamiento de la enfermedad de celíaca en México
J.M. Remes-Troche,L.F. Uscanga-Domínguez,R.G. Aceves-Tavares,A.M. Calderón de la Barca,R.I. Carmona-Sánchez,E. Cerda-Contreras,E. Coss-Adame,M.E. Icaza-Chávez,A. Lopéz-Colombo,M.P. Milke-García,M. Morales-Arámbula,M. Peláez-Luna,P. Ramos Martínez,S. Sánchez-Sosa,M.C. Treviño-Mejía,R. Vázquez-Frías,L.B. Worona-Dibner,L.E. Zamora-Nava,A. Rubio-Tapia
Revista de Gastroenterología de México. 2018;
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    Abstract
    Material & M...
   Results
   Discussion
    References

 Article Access Statistics
    Viewed682    
    Printed9    
    Emailed0    
    PDF Downloaded381    
    Comments [Add]    
    Cited by others 3    

Recommend this journal